Albumin ISH, with 99% sensitivity for HCC detection, addresses gaps in high-grade tumors but shows cross-reactivity in 31.6% of ICCs, necessitating adjunct markers like CK19. The gene discussed is KRT19; the disease is hepatocellular carcinoma.